Diabetic Kidney Drugs, COVID and Diabetes, and a Blood Test for Alzheimer's

Today we compare SGLT2 inhibitors, semaglutide, and finerenone for diabetic kidney disease, explore how SARS-CoV-2 may trigger diabetes through a protein called IAPP, and look at why sex differences affect response to an antibody cancer drug. We also cover a blood test for Alzheimer's disease, an amino acid that calms inflammation, and what a Cochrane review says about pharmaceutical industry influence on prescribing. Plus a quick rundown of other notable studies in autoimmune disease, kidney disease, and more.